Moreover, SLC16A1-AS1 enhances the glucagon signaling pathway effectors PPARA and PHKB, as well as genes that have been shown to mediate bladder cancer invasiveness, such as SNAI2 78 and SH3BGRL 79 (Figure 6D, E). This evidence concerns the gene SLC16A1 and urinary bladder cancer.